High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens - PubMed (original) (raw)
High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens
Justin L Poklis et al. J Anal Toxicol. 2014 Apr.
Abstract
We present a high-performance liquid chromatography triple quadrupole mass spectrometry (HPLC-MS-MS) method for the identification and quantification of nine serotonin 5-HT2A receptor agonist hallucinogenic substances from a new class of N-methoxybenzyl derivatives of methoxyphenylethylamine (NBOMe) designer drugs in human urine: 25H-NBOMe, 2CC-NBOMe, 25I-NBF, 25D-NBOMe, 25B-NBOMe, 2CT-NBOMe, 25I-NBMD, 25G-NBOMe and 25I-NBOMe. This assay was developed for the Virginia Commonwealth University Clinical and Forensic Toxicology laboratory to screen emergency department specimens in response to an outbreak of N-benzyl-phenethylamine derivative abuse and overdose cases in Virginia. The NBOMe derivatives were rapidly extracted from the urine specimens by use of FASt™ solid-phase extraction columns. Assay performance was determined as recommended for validation by the Scientific Working Group for Forensic Toxicology (SWGTOX) for linearity, lower limit of quantification, lower limit of detection, accuracy/bias, precision, dilution integrity, carryover, selectivity, absolute recovery, ion suppression and stability. Linearity was verified to be from 1 to 100 ng/mL for each of the nine analytes. The bias determined for the NBOMe derivatives was 86-116% with a <14% coefficient of variation over the linear range of the assay. Four different NBOMe derivatives were detected using the presented method in patient urine specimens.
Figures
Figure 1.
Structure of the NBOMe derivatives.
Figure 2.
The chromatographic separation of nine NBOMe derivatives and 25I-NBOMe-d3, the ISTD.
Similar articles
- High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.
Poklis JL, Charles J, Wolf CE, Poklis A. Poklis JL, et al. Biomed Chromatogr. 2013 Dec;27(12):1794-800. doi: 10.1002/bmc.2999. Epub 2013 Jul 25. Biomed Chromatogr. 2013. PMID: 23893863 Free PMC article. - Retrospective Demonstration of 25I-NBOMe Acute Poisoning Using Hair Analysis.
Ameline A, Farrugia A, Raul JS, Kintz P. Ameline A, et al. Curr Pharm Biotechnol. 2017;18(10):786-790. doi: 10.2174/1389201019666171129175148. Curr Pharm Biotechnol. 2017. PMID: 29189143 - Severe 25E-NBOH intoxication associated with MDPHP intake: a case report, metabolism study, and literature review.
Pelletier R, Gicquel T, Carvelli J, Balaz P, Pelissier-Alicot AL, Morel I, Bottinelli C, Solas C, Le Daré B, Fabresse N. Pelletier R, et al. Int J Legal Med. 2024 May;138(3):815-822. doi: 10.1007/s00414-023-03151-6. Epub 2023 Dec 20. Int J Legal Med. 2024. PMID: 38117418 Review. - Alpha-methyltryptamine and 5-(2-methylaminopropyl)-benzofuran (5-MAPB) fatal co-intoxication: case report and review of literature.
Epain M, Cartiser N, Bevalot F, Bottinelli C, Chatenay C, Fanton L. Epain M, et al. Int J Legal Med. 2024 Sep;138(5):1813-1820. doi: 10.1007/s00414-024-03236-w. Epub 2024 Apr 23. Int J Legal Med. 2024. PMID: 38649548 Review.
Cited by
- Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
Laskowski LK, Elbakoush F, Calvo J, Exantus-Bernard G, Fong J, Poklis JL, Poklis A, Nelson LS. Laskowski LK, et al. J Med Toxicol. 2015 Jun;11(2):237-41. doi: 10.1007/s13181-014-0445-9. J Med Toxicol. 2015. PMID: 25387562 Free PMC article. - Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication.
Poklis JL, Dempsey SK, Liu K, Ritter JK, Wolf C, Zhang S, Poklis A. Poklis JL, et al. J Anal Toxicol. 2015 Oct;39(8):607-16. doi: 10.1093/jat/bkv079. J Anal Toxicol. 2015. PMID: 26378134 Free PMC article. - Analysis of 2,5-dimethoxy-amphetamines and 2,5-dimethoxy-phenethylamines aiming their determination in biological matrices: a review.
Nieddu M, Baralla E, Sodano F, Boatto G. Nieddu M, et al. Forensic Toxicol. 2023 Jan;41(1):1-24. doi: 10.1007/s11419-022-00638-6. Epub 2022 Sep 14. Forensic Toxicol. 2023. PMID: 36652064 Free PMC article. Review. - Recommendations for specimen collection for NBOMe analysis in clinical toxicology.
Poklis JL, Wolf CE, Nanco CR, Poklis A. Poklis JL, et al. Clin Toxicol (Phila). 2016;54(2):161-2. doi: 10.3109/15563650.2015.1118489. Epub 2015 Dec 22. Clin Toxicol (Phila). 2016. PMID: 26696362 Free PMC article. No abstract available. - HPLC-MS-MS Determination of ZCZ-011, A Novel Pharmacological Tool for Investigation of the Cannabinoid Receptor in Mouse Brain Using Clean Screen FASt™ Column Extraction.
Poklis JL, Clay DJ, Ignatowska-Jankowska BM, Zanato C, Ross RA, Greig IR, Abdullah RA, Mustafa MA, Lichtman AH, Poklis A. Poklis JL, et al. J Anal Toxicol. 2015 Jun;39(5):353-8. doi: 10.1093/jat/bkv015. Epub 2015 Mar 3. J Anal Toxicol. 2015. PMID: 25737338 Free PMC article.
References
- Geyer M.A., Vollenweider F.X. Serotonin research: contributions to understanding psychoses. Trends in Pharmacological Sciences. 2008;29:445–453. - PubMed
- Abbas A., Roth B.L. Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders. Expert Opinion on Pharmacotherapy. 2008;9:3251–3259. - PubMed
- Nichols D.E. Hallucinogens. Pharmacology and Therapeutics. 2004;101:131–181. - PubMed
- Shulgin A.T., Carter M.F. Centrally active phenethylamines. Psychopharmacol Commun. 1975;1:93–98. - PubMed
- Shulgin A., Shulgin A. Berkeley, CA: Transform Press; 1991. PIHKAL: A Chemical Love Story.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources